Current approaches of nanomedicines in the market and various stage of clinical translation
Chinese Academy of Sciences · Shanghai Institute of Materia Medica · +2 more institutions
Abstract
Compared with traditional drug therapy, nanomedicines exhibit intriguing biological features to increase therapeutic efficiency, reduce toxicity and achieve targeting delivery. This review provides a snapshot of nanomedicines that have been currently launched or in the clinical trials, which manifests a diversified trend in carrier types, applied indications and mechanisms of action. From the perspective of indications, this article presents an overview of the applications of nanomedicines involving the prevention, diagnosis and treatment of various diseases, which include cancer, infections, blood disorders, cardiovascular diseases, immuno-associated diseases and nervous system diseases, etc. Moreover, the…
Citation impact
- FWCI
- 22.36
- Percentile
- 100%
- References
- 200
Authors
6- XSXiaoting Shan
Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences
- XGXiang Gong
Chinese Academy of Sciences, Shanghai Institute of Materia Medica
- JLJie Li
Chinese Academy of Sciences, Shanghai Institute of Materia Medica
- JWJingyuan Wen
University of Auckland
- YLYaping Li
Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences
Topics & keywords
- Medicine
- Intensive care medicine
- Clinical trial
- Risk analysis (engineering)
- Pathology
- Good health and well-being